Celldex Therapeutics Inc. (CLDX) climbed 10.32% or 0.26 to $2.73. It is close to 4.29 million shares traded, which is 340.49% compare to the average total volume 1.26 million. The market cap of CLDX is $370.56 million. The year to date change is -15.41%. The 52 week price range is from $2.2 to $3.75. Price of CLDX have changed 9.29% during last week. It have changed -2.76% over last month, -14.83% over last 3 months, -0.80% over last 6 months and -35.17% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLDX is 2.64. It is -3.30% below current price. The 200-day Moving Averages for CLDX is 2.66. It is -2.56% below current price. The 52-week High is 3.75. It is 37.36% from the current price. The 52-week Low is 2.2. It is -19.41% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLDX is 6.91 on 2018-02-15. Short % to float is 6.36%. There are some statistics of CLDX. It is has market cap $370.56 million. The share outstanding is 135.99 million. The average volume is 1.26 million. The revenue is 11.16M. The percent of top 15 Institution holding is 43.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLDX is -54.50%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLDX is -41.71%.